Latest Breaking News On - ஹர்டடோ டி மெண்டோசா - Page 1 : comparemela.com

New tumor-penetrating therapy may improve outcomes in patients with pancreatic cancer Every 12 minutes, someone in the United States dies of pancreatic cancer, which is often diagnosed late, spreads rapidly and has a five-year survival rate at approximately 10 percent. Treatment may involve radiation, surgery and chemotherapy, though often the cancer becomes resistant to drugs. Researchers at University of California San Diego School of Medicine and Moores Cancer Center, in collaboration with Sanford-Burnham-Prebys Medical Discovery Institute and Columbia University, demonstrated that a new tumor-penetrating therapy, tested in animal models, may enhance the effects of chemotherapy, reduce metastasis and increase survival. The study, published online March 9, 2021 in

San-diego
California
United-states
University-of-california-san-diego
Andrew-lowy
Emily-henderson
Discovery-institute
Nature-communications
Uc-san-diego-health
Columbia-university
Moores-cancer-center
Uc-san-diego-school-of-medicine